Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02745444
Other study ID # CR_LSP
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date April 2015
Est. completion date May 2020

Study information

Verified date September 2021
Source University of Cologne
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The key objective of this pilot study is to assess the molecular mechanisms of renal pre-conditioning by a one-week low-calorie diet in humans. The protective effect of the low-calorie diet and also of the protein-restriction in donor on transplant qualities and functions in receptor will also be investigated. Analysis of transcriptome, lipidome, metabolome, epigenome, proteome und phosphoproteome through tissue samples as well as blood samples for comparison of low-calorie diet, protein-restriction and no-diet groups.


Recruitment information / eligibility

Status Completed
Enrollment 40
Est. completion date May 2020
Est. primary completion date May 17, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Age =18 years - Competent patients - Planned living kidney transplantation - Provision of informed consent - BMI = 18,5 kg/m² Exclusion Criteria: - None

Study Design


Intervention

Dietary Supplement:
low-calorie formula diet

protein-restricted diet


Locations

Country Name City State
Germany University Hospital of Cologne Cologne

Sponsors (1)

Lead Sponsor Collaborator
University of Cologne

Country where clinical trial is conducted

Germany, 

Outcome

Type Measure Description Time frame Safety issue
Primary Number of differentially regulated genes on a transcriptomic level Identification of relevant difference with regard to transcriptome in kidney tissue between patients with low-calorie diet and and no-diet patients. up to 1 year upon receipt of the last tissue sample
Primary Number of differentially regulated genes on a lipidome level Identification of relevant difference with regard to lipidome in kidney tissue between patients with low-calorie diet and and no-diet patients. up to 2 years upon receipt of the last tissue sample
Primary Number of differentially regulated genes on a metabolome level Identification of relevant difference with regard to metabolome in kidney tissue between patients with low-calorie diet and and no-diet patients. up to 2 years upon receipt of the last tissue sample
Primary Number of differentially regulated genes on a epigenome level Identification of relevant difference with regard to epigenome in kidney tissue between patients with low-calorie diet and and no-diet patients. up to 2 years upon receipt of the last tissue sample
Primary Number of differentially regulated genes on a proteome level Identification of relevant difference with regard to proteome in kidney tissue between patients with low-calorie diet and and no-diet patients. up to 1 year upon receipt of the last tissue sample
Primary Number of differentially regulated genes on a phosphoproteome level Identification of relevant difference with regard to phosphoproteome in kidney tissue between patients with low-calorie diet and and no-diet patients. up to 2 years upon receipt of the last tissue sample
Secondary Change of NGAL in urine Change of NGAL in urine, marker for kidney damage measured preoperative in donor and receptor. Preoperative from donor and receptor; 6h, 12h and 24h after renal transplantation from receptor.
Secondary Cystatin C Marker for kidney damage measured preoperative and daily until Day 7 postoperative in receptor. Preoperative and up until 7 days after renal transplantation from receptor.
Secondary Occurrence of acute kidney injury Occurrence of acute kidney injury according to KDIGO I, II, III in receptor. Assessed up to approx. 30 days from date of renal transplantation until date of discharge, which is the end of observation.
Secondary Maximum postoperative serum creatinine Maximum postoperative serum creatinine of receptor during hospital stay. Assessed up to approx. 30 days from date of renal transplantation until date of discharge, which is the end of observation.
See also
  Status Clinical Trial Phase
Completed NCT05491642 - A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single and Multiple Doses Phase 1
Recruiting NCT06363097 - Urinary Uromodulin, Dietary Sodium Intake and Ambulatory Blood Pressure in Patients With Chronic Kidney Disease
Terminated NCT04043026 - The Effects of Renal Function and Atrial Fibrillation on Lipoproteins and Clot Structure/Function
Completed NCT05318014 - Low-protein Formula Supplements in Chronic Kidney Disease N/A
Active, not recruiting NCT06071065 - Clinical Pharmacist Intervention on Medication Adherence and Clinical Outcomes in Chronic Kidney Disease Patients N/A
Completed NCT02878317 - Skin Autofluorescence as a Risk Marker in People Receiving Dialysis.
Not yet recruiting NCT06039254 - Safety and Pharmacokinetics of HRS-1780 in Healthy Subjects and Subjects With Impaired Renal Function Phase 1
Recruiting NCT03160326 - The QUALITY Vets Project: Muscle Quality and Kidney Disease
Completed NCT02756520 - Observational Study on CKD Treatment With a Ketosteril Supplemented Protein-restricted Diet (Keto-024-CNI)
Completed NCT02888171 - Impact of Ferric Citrate vs Ferrous Sulfate on Iron Parameters and Hemoglobin in Individuals With CKD and Iron Deficiency N/A
Completed NCT02875886 - DD-study: Diet or Diuretics for Salt-sensitivity in Chronic Kidney Disease Phase 4
Completed NCT02896309 - The Effect of Correction of Metabolic Acidosis in CKD on Intrarenal RAS Activity N/A
Withdrawn NCT02885545 - The Strategy to Prevent Hemorrhage Associated With Anticoagulation in Renal Disease Management (STOP HARM) Trial Phase 4
Completed NCT02836574 - A Study of Renal Autologous Cell Therapy (REACT) in Type 2 Diabetics With Chronic Kidney Disease Phase 2
Active, not recruiting NCT02483039 - Nephrologist Follow-up Versus Usual Care After an Acute Kidney Injury Hospitalization N/A
Completed NCT02369549 - Micro-Particle Curcumin for the Treatment of Chronic Kidney Disease Phase 3
Completed NCT02992548 - Effect of Pravastatin on Erythrocyte Membrane Fatty Acid Contents in Patients With Chronic Kidney Disease Phase 4
Terminated NCT02543177 - Optimised Procedure in Patients With NSTEMI and CKD N/A
Recruiting NCT02205944 - Impact of Presurgical Exercise on Hemodialysis Fistula Outcomes N/A
Active, not recruiting NCT02231138 - Efficacy and Safety of Abelmoschus Manihot for Chronic Kidney Disease Phase 4